The most comprehensive and go-to place for all short selling reseach reports online.
Currently a total of 275 research reports from 14 investment research firms has been aggregated, with new reports being added and updated constantly
ALL
Fuzzy Panda Research(8)
Hindenburg Research(52)
MuddyWaters(44)
Blue Orca Capital(35)
Gotham City Research LLC(11)
Anonymous Analytics(5)
J Capital Research(26)
Grizzly Research LLC(22)
Jehoshaphat Research(10)
Culper Research(20)
Ningi Research(4)
Night Market Research(14)
Ontake Research(2)
Bonitas Research(22)
ALL
0067(1)
0607(1)
0773(1)
1044(1)
1228(1)
1259(1)
1360(6)
1619(1)
1636(1)
1717(1)
1910(1)
1999(1)
2018(1)
2020(1)
2200(1)
3823(1)
3836(1)
3998(1)
404(1)
4587(1)
496(1)
555(1)
6186(1)
6594(1)
669.HK(1)
6863(1)
8207(2)
867(1)
ACB(1)
ACMR(1)
AGFY(1)
AHCO(1)
AHG(1)
AMEH(1)
AMT(1)
AMTX(1)
AOS(1)
APHA(1)
AR4(1)
AR4.DE(1)
ARMC(1)
ARRY(1)
ATEC(1)
ATER(1)
ATRC(1)
BCOR(1)
BDSI(1)
BE(1)
BEKE(1)
BGNE(1)
BLA(1)
BLNK(1)
BOO(1)
BRP(1)
BTBT(1)
BTCM(1)
BUR(1)
BWXT(1)
BYSI(1)
CBAT(1)
CCME(1)
CCRC(1)
CDXC(1)
CELH(1)
CGN(1)
CLOV(1)
CLSK(1)
CMC(1)
CMED(1)
CO(1)
CORT(1)
CORZ(1)
CRIUF(1)
CRMD(1)
CRTO(1)
CSSE(1)
CYDY(1)
DATS(1)
DGW(1)
DKNG(1)
DNMR(1)
DOS(1)
DOYU(1)
DVA(1)
EBIX(1)
EBON(1)
EDU(1)
EHTH(1)
EIGU(1)
ELMS(1)
EMO(1)
ENOB(1)
ENPH(1)
EROS(1)
EVER(1)
EVGO(1)
FANH(1)
FCEL(1)
FD(1)
FFIE(1)
FIZZ(1)
FMCN(1)
FRGT(1)
FRSX(1)
FUV(1)
GAU(1)
GDS(2)
GFRE(1)
GGR(1)
GNPX(1)
GNUS(1)
GNW(1)
GOTU(2)
GOW(1)
GRWG(1)
GWH(2)
HASI(2)
HFFG(1)
HMBL(1)
HPR(1)
HROW(2)
HTHT(1)
HYLN(1)
HYZN(1)
IBAT(1)
IDEX(2)
IIPR(1)
INGN(1)
INPX(1)
INS(1)
IPO(1)
IQE(1)
ITP(1)
JCOM(1)
JD(1)
JKS(1)
KERN(1)
KIDS(1)
KNDI(1)
KRZ(1)
LICY(1)
LK(1)
LKE(1)
LKM(1)
LLEN(1)
LMFD(1)
LMND(1)
LOOP(1)
LTS(1)
LX(1)
MARA(2)
MARK(1)
MDCA(1)
MED(1)
MFC(1)
MNSO(1)
MP(2)
MPLN(1)
MULN(1)
MVMD(1)
MXL(1)
N/A(1)
NAK(1)
NB2(1)
NBEV(1)
NEA(1)
NEWP(1)
NEXCF(1)
NG(1)
NIO(1)
NISN(1)
NKLA(1)
NMC(1)
NNOX(1)
NOBGY(1)
NRGV(1)
NTRA(1)
NYMX(1)
OLAG(1)
ONDS(1)
OPK(1)
OPRA(1)
ORA(1)
OSIS(1)
OTRK(1)
PCLO(1)
PCYO(1)
PETS(1)
PGLC(1)
PGNY(1)
PKK(1)
PLL(2)
PLSE(1)
PLTK(1)
PRED(1)
PRTA(1)
PUMP(1)
PVBC(1)
QPP(1)
RFF(1)
RIDE(1)
RINO(1)
RIOT(1)
ROLTA(1)
RUN(1)
S30(1)
SAX(1)
SDC(1)
SEK(1)
SEV(1)
SGLY(1)
SKYS(1)
SLI(2)
SOL(1)
SOS(1)
SPI(1)
SPRD(1)
SRNE(2)
SSTI(1)
STAA(1)
STEM(1)
STJ(1)
SY(1)
TAL(1)
TELIA(1)
TFC(1)
TGLS(1)
TMC(1)
TMCI(1)
TRE(1)
TRUL(1)
TSP(1)
TTSH(1)
TWTR(1)
UAVS(1)
UNH(1)
UTA(1)
VBIV(1)
VERI(1)
VERU(1)
VIEW(1)
WELL(1)
WINS(1)
WKHS(1)
WORX(1)
WTC(1)
WU(1)
WUBA(1)
XL(1)
XMTR(1)
XXII(1)
YMM(1)
YRIV(1)
YY(1)
ZEN(1)
ZNOG(1)
ZTO(1)
ZYXI(1)
Current Share Price: 60.630
MuddyWaters
Initial Report Date（2017/06/29）Share Price:54.450
Initial Report Date（2017/06/29）Share Price:54.450
MW is Short Prothena Corp PLC (PRTA:US)
Details Link > We are short PRTA. The publicly-available data, in our opinion, does not show that NEOD001 is efficacious. Our impression appears to run contrary to that of the sell-side. We believe that perceived positive responses to the drug are quite possibly – if not likely – due to previous plasma cell directed (“PCD”) therapy, and also to the manner in which some early trial data has been presented. Further, NEOD001’s proposed mechanism of action is not proven.
By wantattse
Start
